David G. Bostwick

2.4k total citations · 1 hit paper
15 papers, 1.9k citations indexed

About

David G. Bostwick is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, David G. Bostwick has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Rheumatology. Recurrent topics in David G. Bostwick's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (6 papers) and Urologic and reproductive health conditions (4 papers). David G. Bostwick is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (6 papers) and Urologic and reproductive health conditions (4 papers). David G. Bostwick collaborates with scholars based in United States, Canada and Germany. David G. Bostwick's co-authors include Kenneth A. Iczkowski, Kiran Adlakha, John N. Eble, Mohammed A. Amin, Brett Delahunt, Erik J. Bergstralh, Horst Zincke, Michael L. Blute, Robert B. Jenkins and John C. Cheville and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and The American Journal of Surgical Pathology.

In The Last Decade

David G. Bostwick

15 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification of renal cell carcinoma

1997 705 citations John N. Eble, Kiran Adlakha et al. Cancer profile →

Peers

Countries citing papers authored by David G. Bostwick

Since Specialization

Citations

This map shows the geographic impact of David G. Bostwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Bostwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Bostwick more than expected).

Fields of papers citing papers by David G. Bostwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Bostwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Bostwick. The network helps show where David G. Bostwick may publish in the future.

Co-authorship network of co-authors of David G. Bostwick

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Bostwick. A scholar is included among the top collaborators of David G. Bostwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Bostwick. David G. Bostwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Human acid ceramidase is overexpressed but not mutated in prostate cancer 2000 ·Genes Chromosomes and Cancer ·Ratnam S. Seelan, Chiping Qian, Akira Yokomizo, David G. Bostwick, Jeremy C. Smith, Wanguo Liu	132
2	Clinical Significance of Alterations of Chromosome 8 in High-Grade, Advanced, Nonmetastatic Prostate Carcinoma 1999 ·JNCI Journal of the National Cancer Institute ·Kazunari Sato, J. Qian, (unknown), Michael M. Lieber, David G. Bostwick, Erik J. Bergstralh, Robert B. Jenkins	172
3	Prevalence and Distribution of Prostatic Intraepithelial Neoplasia in Salvage Radical Prostatectomy Specimens After Radiation Therapy 1999 ·The American Journal of Surgical Pathology ·Liang Cheng, John C. Cheville, Thomas M. Pisansky, Thomas J. Sebo, Jeff Slezak, Erik J. Bergstralh, Roxann M. Neumann, Rohini Singh, Anna Pacelli, Horst Zincke, David G. Bostwick	28
4	High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer 1998 ·The Prostate ·Joseph W. Aquilina, LuAnn McKinney, Anna Pacelli, Laura K. Richman, David J. Waters, Ian M. Thompson, W Burghardt, David G. Bostwick	32
5	Influence of Prostate-Specific Antigen Testing on the Spectrum of Patients With Prostate Cancer Undergoing Radical Prostatectomy at a Large Referral Practice 1998 ·Mayo Clinic Proceedings ·Christopher L. Amling, Michael L. Blute, (unknown), (unknown), David G. Bostwick, Horst Zincke	68
6	Independent origin of multiple foci of prostatic intraepithelial neoplasia 1998 ·Cancer ·David G. Bostwick, Ailin Shan, Junqi Qian, (unknown), Nita J. Maihle, Robert B. Jenkins, Liang Cheng	133
7	Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. 1998 ·Mayo Clinic Proceedings ·Christopher L. Amling, Michael L. Blute, (unknown), Erik J. Bergstralh, David G. Bostwick, Horst Zincke	18
8	The Focus of “Atypical Glands, Suspicious for Malignancy” in Prostatic Needle Biopsy Specimens:Incidence, Histologic Features, and Clinical Follow-Up of Cases Diagnosed in a Community Practice 1997 ·American Journal of Clinical Pathology ·John C. Cheville, (unknown), David G. Bostwick	116
9	Intestinal metaplasia is not a strong risk factor for bladder cancer: Study of 53 cases with long-term follow-up 1997 ·Urology ·Federico A. Corica, Douglas A. Husmann, Bernard M. Churchill, Robert H. Young, Anna Pacelli, Antonio López-Beltrán, David G. Bostwick	80
10	Classification of renal cell carcinoma breakdown → 1997 ·Cancer ·(unknown), John N. Eble, Kiran Adlakha, Mohammed A. Amin, (unknown), David G. Bostwick, (unknown), Brett Delahunt, Kenneth A. Iczkowski	705
11	Anatomic site-specific positive margins in organconfined prostate cancer and its impact on outcome after radical prostatectomy 1997 ·Urology ·Michael L. Blute, David G. Bostwick, Erik J. Bergstralh, Jeff Slezak, Sandra K. Martin, Christopher L. Amling, Horst Zincke	236
12	The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. 1997 ·PubMed ·David J. Waters, David G. Bostwick	41
13	Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia 1996 ·Cancer ·David G. Bostwick	127
14	CT of Erdheim-Chester Disease Presenting as Retroperitoneal Xanthogranulomatosis 1994 ·Journal of Computer Assisted Tomography ·(unknown), (unknown), Ronald G. Swee, David G. Bostwick, (unknown)	12
15	Alterations in glycoconjugate expression following malignant transformation of human oropharyngeal squamous mucosa 1989 ·The Laryngoscope ·(unknown), Reza Mostofi, David G. Bostwick	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact